August 04, 2026 05:19 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kejriwal marches to PM Modi's residence over E20 petrol, alleges 'Trump pressure' behind policy | DMK slams Vijay government over Udhayanidhi's arrest, calls it 'blatant cowardice' | Tamil Nadu political storm: Udhayanidhi Stalin arrested after Trisha remark row | Faridabad teacher stabbed 34 times in 30 seconds at school gate; shocking CCTV details emerge | 'It was a conspiracy': Brij Bhushan reacts after acquittal in wrestlers' sexual harassment case | After NEET protests, CJP backs Jharkhand students' agitation over alleged JPSC-JSSC exam irregularities | Brij Bhushan acquitted: Delhi Court clears ex-WFI chief in high-profile wrestlers' sexual harassment case | India finishes 4th at Commonwealth Games 2026 with 39 medals despite missing medal-rich sports | Kulgam terror attack turns deadlier: Second Chhattisgarh worker succumbs to bullet injuries | 'I'm ashamed': Girl who abused PM Modi during NEET protests issues apology
Johnson Baby Powder
Image Credit: wikipedia.org

Maharashtra FDA cancels Johnson & Johnson baby powder licence

| @indiablooms | Sep 18, 2022, at 05:06 am

Mumbai: The Maharashtra FDA has cancelled the baby talcum powder manufacturing licence of Johnson & Johnson, Mulund, after the department found it "Not Of Standard Quality".

The FDA said that the licence was cancelled after samples of the Johnson’s Baby Powder collected from Nashik and Pune failed quality checks and ordered the company to recall all its stocks from the markets.

These samples were declared by the FDA as ‘Not Of Standard Quality’ after they failed to comply with IS5339:2009 (Second Revision Amendment No. 3) Specification for Skin Powder for infants in the test pH.

In a statement, the FDA said: “The product Johnsons Baby Powder is popularly used in newborn babies. The sample declared 'Not of Standard' in pH and the use of the product may affect the health of the skin of the newborn babies.”

The firm "didn't accept the report" and challenged it in court for sending it to the Central Drugs Laboratory, the FDA said, according to media reports.

(With UNI inputs)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.